Mariko Kajikawa

2.4k citations

36 papers · 1.8k indexed · 1 hit paper · h-index 18

Cardiology and Cardiovascular Medicine top 2%
Internal Medicine top 0.5%
Surgery top 10%
Endocrinology, Diabetes and Metabolism top 5%
Molecular Biology

Co-authors: Masahiro Tajiri Hitoshi Ueda Masaharu Kato Tohru Izumi Masayasu Matsumoto Shinya Goto Shin‐ichi Momomura Norio Tanahashi
Topics: Atrial Fibrillation Management and Outcomes (14 papers)Pancreatic function and diabetes (12 papers)Cardiac Arrhythmias and Treatments (9 papers)
Cited by: Internal Medicine Cardiology and Cardiovascular Medicine Endocrinology, Diabetes and Metabolism
Journals: Proceedings of the National Academy of Sciences Diabetes Biochemical and Biophysical Research Communications
Partner nations: Japan Germany United States

In The Last Decade

Mariko Kajikawa

36 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rivaroxaban vs. Warfarin in Japanese Patients With Atrial Fibrillation

2012 477 citations Masatsugu Hori, Masayasu Matsumoto et al. profile →

Peers

Countries citing papers authored by Mariko Kajikawa

Since Specialization

Citations

This map shows the geographic impact of Mariko Kajikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mariko Kajikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mariko Kajikawa more than expected).

Fields of papers citing papers by Mariko Kajikawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mariko Kajikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mariko Kajikawa. The network helps show where Mariko Kajikawa may publish in the future.

Co-authorship network of co-authors of Mariko Kajikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Mariko Kajikawa. A scholar is included among the top collaborators of Mariko Kajikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mariko Kajikawa. Mariko Kajikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Predictive factors for bleeding during treatment with rivaroxaban and warfarin in Japanese patients with atrial fibrillation – Subgroup analysis of J-ROCKET AF 2016 ·Journal of Cardiology ·Masatsugu Hori,Masayasu Matsumoto,Norio Tanahashi,Shin‐ichi Momomura,Shinichiro Uchiyama,Shinya Goto,Tohru Izumi,Yukihiro Koretsune,Mariko Kajikawa,Masaharu Kato,(unknown),Kazuma Iekushi,Satoshi Yamanaka	13
2	Long-term safety and efficacy of high-dose controlled-release nifedipine (80 mg per day) in Japanese patients with essential hypertension 2015 ·Hypertension Research ·Kazuaki Shimamoto,(unknown),Yoshimi Matsuda,(unknown),Mariko Kajikawa	8
3	Rivaroxaban vs. Warfarin in Japanese Patients With Non-Valvular Atrial Fibrillation in Relation to Age:– Insight From J-ROCKET AF – 2014 ·Japanese Circulation Journal-english Edition ·Masatsugu Hori,Masayasu Matsumoto,Norio Tanahashi,Shin‐ichi Momomura,Shinichiro Uchiyama,Shinya Goto,Tohru Izumi,Yukihiro Koretsune,Mariko Kajikawa,Masaharu Kato,Hitoshi Ueda,Kazuma Iekushi,Satoshi Yamanaka,Masahiro Tajiri	3
4	Rivaroxaban versus warfarin in Japanese patients with non-valvular atrial fibrillation in relation to hypertension: a subgroup analysis of the J-ROCKET AF trial 2014 ·Hypertension Research ·(unknown),Masayasu Matsumoto,Masatsugu Hori,Norio Tanahashi,Shin‐ichi Momomura,Shinichiro Uchiyama,Shinya Goto,Tohru Izumi,Yukihiro Koretsune,Mariko Kajikawa,Masaharu Kato,Hitoshi Ueda,Kazuma Iekushi,Satoshi Yamanaka,Masahiro Tajiri	9
5	Confirmation of Model-based Dose Selection for a Japanese Phase III Study of Rivaroxaban in Non-valvular Atrial Fibrillation Patients 2013 ·Drug Metabolism and Pharmacokinetics ·(unknown),Takahiko Tanigawa,(unknown),Mariko Kajikawa,Masahiro Tajiri,Wolfgang Mueck	45
6	Rivaroxaban versus Warfarin in Japanese Patients with Nonvalvular Atrial Fibrillation in Relation to the CHADS2 Score: A Subgroup Analysis of the J-ROCKET AF Trial 2013 ·Journal of Stroke and Cerebrovascular Diseases ·Masatsugu Hori,Masayasu Matsumoto,Norio Tanahashi,Shin‐ichi Momomura,Shinichiro Uchiyama,Shinya Goto,Tohru Izumi,Yukihiro Koretsune,Mariko Kajikawa,Masaharu Kato,Hitoshi Ueda,Kazuma Iekushi,Satoshi Yamanaka,Masahiro Tajiri	13
7	Net Clinical Benefit of Rivaroxaban versus Warfarin in Japanese Patients with Nonvalvular Atrial Fibrillation: A Subgroup Analysis of J-ROCKET AF 2013 ·Journal of Stroke and Cerebrovascular Diseases ·Shinichiro Uchiyama,Masatsugu Hori,Masayasu Matsumoto,Norio Tanahashi,Shin‐ichi Momomura,Shinya Goto,Tohru Izumi,Yukihiro Koretsune,Mariko Kajikawa,Masaharu Kato,Hitoshi Ueda,Kazuma Iekushi,Satoshi Yamanaka,Masahiro Tajiri	11
8	Rivaroxaban versus Warfarin in Japanese Patients with Nonvalvular Atrial Fibrillation for the Secondary Prevention of Stroke: A Subgroup Analysis of J-ROCKET AF 2013 ·Journal of Stroke and Cerebrovascular Diseases ·Norio Tanahashi,Masatsugu Hori,Masayasu Matsumoto,Shin‐ichi Momomura,Shinichiro Uchiyama,Shinya Goto,Tohru Izumi,Yukihiro Koretsune,Mariko Kajikawa,Masaharu Kato,Hitoshi Ueda,Kazuya Iwamoto,Masahiro Tajiri	23
9	Plasma proteomics of patients with non-valvular atrial fibrillation on chronic anti-coagulation with warfarin or a direct factor Xa inhibitor 2012 ·Thrombosis and Haemostasis ·Mark Y. Chan,Min Lin,Joseph Lucas,Arthur Moseley,J. Will Thompson,Derek D. Cyr,Hitoshi Ueda,Mariko Kajikawa,Thomas L. Ortel,Richard Becker	34
10	Model-based Dose Selection for Phase III Rivaroxaban Study in Japanese Patients with Non-valvular Atrial Fibrillation 2012 ·Drug Metabolism and Pharmacokinetics ·Takahiko Tanigawa,(unknown),(unknown),Mariko Kajikawa,Hitoshi Ueda,Masahiro Tajiri,John F. Paolini,Wolfgang Mueck	89
11	A genome-wide gain-of-function analysis of rice genes using the FOX-hunting system 2007 ·Plant Molecular Biology ·Hidemitsu Nakamura,Makoto Hakata,(unknown),Akio Miyao,Naoko Toki,Mariko Kajikawa,Jinhuan Pang,(unknown),(unknown),Seiichi Toki,Miki Fujita,Akiko Enju,Motoaki Seki,Miki Nakazawa,Takanari Ichikawa,Kazuo Shinozaki,Minami Matsui,Yoshiaki Nagamura,Hirohiko Hirochika,Hiroaki Ichikawa	87
12	Impaired metabolism–secretion coupling in pancreatic β-cells: Role of determinants of mitochondrial ATP production 2007 ·Diabetes Research and Clinical Practice ·Shimpei Fujimoto,Koichiro Nabe,(unknown),Makiko Shimodahira,Mariko Kajikawa,(unknown),Eri Mukai,Nobuya Inagaki,Yutaka Seino	28
13	Gene expression property of high-density three-dimensional tissue of HepG2 cells formed in radial-flow bioreactor 2006 ·Journal of Bioscience and Bioengineering ·(unknown),Mariko Kajikawa,Seiichi Ishida,Shogo Ozawa,Yasuo Ohno,Jun‐ichi Sawada,(unknown),Hiroyuki Honda	11
14	Three-dimensional high-density culture of HepG2 cells in a 5-ml radial-flow bioreactor for construction of artificial liver 2005 ·Journal of Bioscience and Bioengineering ·(unknown),Mariko Kajikawa,Seiichi Ishida,Shogo Ozawa,Yasuo Ohno,Jun‐ichi Sawada,Akira Umezawa,(unknown),Takeshi Kobayashi,Hiroyuki Honda	41
15	Ouabain Suppresses Glucose-Induced Mitochondrial ATP Production and Insulin Release by Generating Reactive Oxygen Species in Pancreatic Islets 2002 ·Diabetes ·Mariko Kajikawa,Shimpei Fujimoto,Yoshiyuki Tsuura,Eri Mukai,(unknown),Yoshiyuki Hamamoto,(unknown),Jun Fujita,Yuichiro Yamada,Yutaka Seino	51
16	Heat Shock Restores Insulin Secretion after Injury by Nitric Oxide by Maintaining Glucokinase Activity in Rat Islets 2001 ·Biochemical and Biophysical Research Communications ·(unknown),Yoshiyuki Tsuura,Jun Fujita,Shimpei Fujimoto,Eri Mukai,Mariko Kajikawa,Yoshiyuki Hamamoto,Makoto Kume,Yuzo Yamamoto,Yoshio Yamaoka,Yuichiro Yamada,Yutaka Seino	10
17	The insulinotropic mechanism of the novel hypoglycaemic agent JTT‐608: direct enhancement of Ca²⁺ efficacy and increase of Ca²⁺ influx by phosphodiesterase inhibition 2000 ·British Journal of Pharmacology ·Eri Mukai,Hitoshi Ishida,Shimpei Fujimoto,Mariko Kajikawa,Yoshimasa Okamoto,Jun Fujita,Yoshiyuki Hamamoto,Yoshiyuki Tsuura,Yuichiro Yamada,Noboru Furukawa,Takeshi Ohta,Yutaka Seino	10
18	Regulation of Intracellular ATP Concentration under Conditions of Reduced ATP Consumption in Pancreatic Islets 1999 ·Biochemical and Biophysical Research Communications ·Yoshiyuki Tsuura,Shimpei Fujimoto,Mariko Kajikawa,Hitoshi Ishida,Yutaka Seino	13
19	Necessity of Endogenous GTP Derived from Glucose-6-phosphate for Insulin Secretion Augmented by Glucose under Protein Kinase A Activation 1998 ·Biochemical and Biophysical Research Communications ·(unknown),(unknown),Yoshiyuki Tsuura,Seika Kato,N. Mizuno,Shimpei Fujimoto,Eri Mukai,Mariko Kajikawa,Masaru Usami,Yutaka Seino	4
20	Three Thyroid Patients Showing Fluctuation of Thyroid Hormone Autoantibody Titers during Long-term Treatment 1995 ·Folia Endocrinologica Japonica ·K Ikekubo,Megumu Hino,(unknown),Mariko Kajikawa,Naoki Hattori,(unknown),(unknown),(unknown)	2

About Mariko Kajikawa

Mariko Kajikawa is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism, having authored 36 papers that have together received 1.8k indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (14 papers), Pancreatic function and diabetes (12 papers) and Cardiac Arrhythmias and Treatments (9 papers). The work is most often cited by research in Internal Medicine (540 citations), Cardiology and Cardiovascular Medicine (892 citations) and Endocrinology, Diabetes and Metabolism (392 citations). Mariko Kajikawa has collaborated with scholars based in Japan, Germany and United States. Frequent co-authors include Masahiro Tajiri, Hitoshi Ueda, Masaharu Kato, Tohru Izumi, Masayasu Matsumoto, Shinya Goto, Shin‐ichi Momomura, Norio Tanahashi, Shinichiro Uchiyama and Yutaka Seino. Their work appears in journals such as Proceedings of the National Academy of Sciences, Diabetes and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact